Ginsenoside compound K- a potential drug for rheumatoid arthritis.

Mengshi Tang, Xi Xie, Yongyu Yang, Fen Li

Pharmacological research 2021 Apr

filter terms:

Rheumatoid arthritis (RA) is a chronic inflammatory and autoimmune disease, if prescription of effective delayed, the articular disturbances may lead to disability. Ginsenoside compound K (GCK) is the main degradation product of oral ginsenosides in the human intestine. Numerous researches in vitro and in vivo have recorded the anti-arthritic effect of GCK, we discuss the mechanisms from the following three aspects, including anti-inflammatory, immune-regulatory, and bone-protective, respectively, in this review, and the anti-arthritic mechanism of GCK may be related to the effect on TNF-α-TNFR2, glucocorticoid receptor (GR) and β-arrestin1/2. We also describe the anti-anemia effect of GCK to open the possibility that GCK can be used as an effective disease-modifying anti-rheumatic drug (DMARD). Copyright © 2021 Elsevier Ltd. All rights reserved.

Citation

Mengshi Tang, Xi Xie, Yongyu Yang, Fen Li. Ginsenoside compound K- a potential drug for rheumatoid arthritis. Pharmacological research. 2021 Apr;166:105498